Sei Investments CO Biomarin Pharmaceutical Inc Transaction History

Sei Investments CO

$74.7 Billion
Q3 2024

A detailed history of Sei Investments CO transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Sei Investments CO holds 172,135 shares of BMRN stock, worth $11.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

172,135

Previous 175,431 1.88%

Holding current value

$11.5 Million

Previous $14.4 Million 16.23%

% of portfolio

0.02%

Previous 0.02%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$69.02 - $93.84 $227,489 - $309,296	-3,296 Reduced 1.88%	172,135 $12.1 Million
Q2 2024 Aug 13, 2024	BUY	$74.43 - $92.22 $247,182 - $306,262	3,321 Added 1.93%	175,431 $14.4 Million
Q1 2024 May 07, 2024	BUY	$83.81 - $99.0 $278,081 - $328,482	3,318 Added 1.97%	172,110 $15 Million
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $6,554 - $8,471	86 Added 0.05%	168,792 $16.3 Million
Q3 2023 Nov 14, 2023	SELL	$85.07 - $94.48 $114,078 - $126,697	-1,341 Reduced 0.79%	168,706 $14.9 Million
Q2 2023 Aug 11, 2023	SELL	$86.68 - $100.3 $189,742 - $219,556	-2,189 Reduced 1.27%	170,047 $14.7 Million
Q1 2023 May 12, 2023	BUY	$87.74 - $117.27 $1.05 Million - $1.41 Million	12,000 Added 7.49%	172,236 $16.7 Million
Q4 2022 Feb 10, 2023	BUY	$80.93 - $108.63 $357,872 - $480,361	4,422 Added 2.84%	160,236 $16.6 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $192,993 - $227,712	2,349 Added 1.53%	155,814 $13.2 Million
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $13,223 - $16,067	185 Added 0.12%	153,465 $12.7 Million
Q1 2022 May 13, 2022	SELL	$74.28 - $92.69 $311,158 - $388,278	-4,189 Reduced 2.66%	153,280 $11.8 Million
Q4 2021 Feb 14, 2022	SELL	$71.72 - $91.47 $261,132 - $333,042	-3,641 Reduced 2.26%	157,469 $13.9 Million
Q3 2021 Nov 12, 2021	BUY	$74.77 - $85.47 $31,627 - $36,153	423 Added 0.26%	161,110 $12.4 Million
Q2 2021 Aug 06, 2021	SELL	$75.51 - $84.79 $680,571 - $764,212	-9,013 Reduced 5.31%	160,687 $13.4 Million
Q1 2021 May 12, 2021	SELL	$74.73 - $90.69 $2.74 Million - $3.33 Million	-36,731 Reduced 17.79%	169,700 $12.8 Million
Q4 2020 Feb 08, 2021	SELL	$72.61 - $90.2 $433,191 - $538,133	-5,966 Reduced 2.81%	206,431 $18.1 Million
Q3 2020 Dec 04, 2020	SELL	$71.87 - $131.03 $155,670 - $283,810	-2,166 Reduced 1.01%	212,397 $16.1 Million
Q3 2020 Nov 06, 2020	SELL	$71.87 - $131.03 $14.4 Million - $26.2 Million	-200,255 Reduced 48.28%	214,563 $16.3 Million
Q2 2020 Aug 17, 2020	BUY	$79.55 - $124.22 $17.6 Million - $27.5 Million	221,333 Added 114.39%	414,818 $51.1 Million
Q2 2020 Aug 11, 2020	SELL	$79.55 - $124.22 $11.4 Million - $17.8 Million	-143,020 Reduced 42.5%	193,485 $16.6 Million
Q1 2020 May 14, 2020	BUY	$71.37 - $96.85 $10.6 Million - $14.3 Million	148,059 Added 78.57%	336,505 $28.4 Million
Q4 2019 Feb 06, 2020	BUY	$64.27 - $86.37 $2.42 Million - $3.25 Million	37,645 Added 24.96%	188,446 $15.9 Million
Q3 2019 Nov 12, 2019	BUY	$67.4 - $85.11 $1.89 Million - $2.39 Million	28,023 Added 22.82%	150,801 $10.2 Million
Q2 2019 Aug 14, 2019	SELL	$80.35 - $93.9 $1.3 Million - $1.51 Million	-16,117 Reduced 11.6%	122,778 $10.5 Million
Q1 2019 May 15, 2019	SELL	$84.2 - $98.62 $1.48 Million - $1.73 Million	-17,518 Reduced 11.2%	138,895 $12.3 Million
Q4 2018 Feb 13, 2019	BUY	$80.14 - $106.07 $818,309 - $1.08 Million	10,211 Added 6.98%	156,413 $15 Million
Q3 2018 Nov 08, 2018	BUY	$93.92 - $105.72 $84,528 - $95,148	900 Added 0.62%	146,202 $14.2 Million
Q2 2018 Aug 03, 2018	SELL	$76.01 - $99.03 $93,036 - $121,212	-1,224 Reduced 0.84%	145,302 $13.7 Million
Q1 2018 May 11, 2018	SELL	$77.67 - $92.63 $6.56 Million - $7.82 Million	-84,429 Reduced 36.56%	146,526 $11.9 Million
Q4 2017 Feb 08, 2018	SELL	$80.76 - $95.13 $462,512 - $544,809	-5,727 Reduced 2.42%	230,955 $20.6 Million
Q3 2017 Nov 06, 2017	BUY	$80.6 - $94.95 $19.1 Million - $22.5 Million	236,682	236,682 $22 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account

Sei Investments CO Biomarin Pharmaceutical Inc Transaction History